|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (right to buy) | $ 3.48 | 12/07/2012 | M | 22,103 | (2) | 03/31/2016 | Common Stock | 22,103 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $ 3.48 | 12/07/2012 | M | 331 | (3) | 03/31/2016 | Common Stock | 331 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $ 13.59 | 12/07/2012 | M | 29,432 | (4) | 01/24/2017 | Common Stock | 29,432 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $ 9.8 | 12/07/2012 | M | 10,204 | (5) | 12/13/2017 | Common Stock | 10,204 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $ 7.18 | 12/07/2012 | M | 13,927 | (6) | 12/04/2018 | Common Stock | 13,927 | $ 0 | 0 | D | ||||
Stock Option (right to buy) | $ 6.25 | 12/07/2012 | M | 23,070 | (7) | 01/05/2020 | Common Stock | 23,070 | $ 0 | 340,930 | D | ||||
Stock Option (right to buy) | $ 5.94 | 12/07/2012 | M | 76,930 | (8) | 01/06/2021 | Common Stock | 76,930 | $ 0 | 83,620 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Perkins Adelene Q C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE, MA 02139 |
X | Pres & Chief Executive Officer |
/s/Adelene Q. Perkins | 12/10/2012 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Represents shares of Infinity Pharmaceuticals, Inc. common stock acquired under the Infinity Pharmaceuticals, Inc. 401(k) plan. |
(2) | This option was fully vested with respect to all 22,103 shares subject to the option as of the date hereof. |
(3) | This option was fully vested with respect to all 331 shares subject to the option as of the date hereof. |
(4) | This option was fully vested with respect to all 29,432 shares remaining subject to the option as of the date hereof. |
(5) | This option was fully vested with respect to all 10,204 shares remaining subject to the option as of the date hereof. |
(6) | This option was fully vested with respect to all 13,927 shares remaining subject to the option as of the date hereof. |
(7) | This option was vested with respect to 265,416 shares as of the date hereof and vests as to 1/48th of the 364,000 shares subject to the initial option at the end of each calendar month. |
(8) | This option was vested with respect to 76,930 shares as of the date hereof and vests as to 1/48th of the 160,550 shares subject to the initial option at the end of each calendar month. |